Connections Archive

Connections Newsletter -- Spring 2013
Feature Stories
- National Effort Against Alzheimer’s Ramps Up
- New Alzheimer’s Prevention Registry recruiting 250,000 volunteers
- "Connecting to Combat Alzheimer's" project wins HHSinnovates awards
NIA News & Research Highlights
- Analysis finds gene variants associated with Alzheimer’s amyloid deposition
- Minority Recruitment: Translating General Principles Into Specific Strategies (from LINKS: Minority Research & Training, Winter 2013)
Upcoming events:
- Alzheimer’s Disease-Related Dementias: Research Challenges and Opportunities workshop, May 1-2
- Join NIA to honor Dr. Robert Butler with May 8 memorial lecture:Neuroimaging and Biomarkers: How Early Can We Diagnose Alzheimer's?
Also of Note
- The ADEAR Center is tweeting! Follow us on Twitter@Alzheimers_NIH!
- Looking for funding opportunities? Current NIA funding opportunities and announcements
- New online tip sheets for Alzheimer’s caregivers:
- Going to the Hospital (PDF, 502K)
- Home Safety (PDF, 356K)
- Traveling Overnight (PDF, 425K)
- More free resources from the ADEAR Center
Clinical Trials Now Recruiting
Major Studies:
- Alzheimer’s Disease Neuroimaging Initiative—seeking Vietnam War veterans for a new study of brain aging, as well as older adults with a significant memory concern but no signs of cognitive impairment for a study to define biological markers and structural brain changes of Alzheimer’s (multiple sites)
- Dominantly Inherited Alzheimer’s Network (DIAN)—seeking adult children age 18 and older with a biological parent who has a known genetic mutation for Alzheimer’s (multiple sites)
- Systolic Blood Pressure Intervention Trial: Memory and Cognition in Decreased Hypertension (SPRINT-MIND)—recruiting volunteers age 50 or older with high blood pressure—systolic (upper) number of at least 130—who have a history of heart disease or chronic kidney disease or are at risk for heart disease, but with no history of diabetes or stroke (multiple sites)
Drug Trials:
- PF-05212377 for People with Alzheimer’s Disease and Neuropsychiatric Symptoms
- BAN2401 for Early Alzheimer’s Disease
- Bisnorcymserine in Healthy Adult Volunteers
- Effects of EVP-0962 on Amyloid Levels in Cerebrospinal Fluid
- ELND005 for Agitation and Aggression in Alzheimer’s Disease
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia (DIAN TU)
Brain Imaging and Biomarker Studies:
- Florbetapir (18F) PET Imaging Effectiveness in Management of Patients with Cognitive Decline
- Arterial Spin Labeling MRI for Cognitive Decline
- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Other Dementias
- Effects of Simvastatin on Biomarkers
Non-Alzheimer's Dementias:
Other Trials:
- Aerobic Exercise in Early Alzheimer’s Disease
- Effects of Fruitflow-II and Resveratrol on Memory, Fitness, and Cerebral Blood Flow
- Memory Consolidation in Obstructive Sleep Apnea
- PhytoSERMs for Menopause Symptoms and Age-Associated Memory Decline
Connections Newsletter -- Winter 2013
New Research Resources
- Latest NIH Alzheimer’s Research Progress Report Available
- The NIH "Toolbox" Is Open
- New Database Aims to Capture International Alzheimer’s Disease Research Efforts
NIA News & Research Highlights
- NIH-supported Alzheimer’s studies to focus on innovative treatments (January 14, 2013)
- NIA researchers find protein PGC-1alpha may play important role in brain health (December 12, 2012)
- NIH-supported international teams identify rare Alzheimer’s disease risk gene variant (November 15, 2012)
- Dr. Neil Buckholtz named head of Division of Neuroscience (October 2, 2012)
- Risk gene for Alzheimer’s disease associated with lower brain amyloid (October 1, 2012)
- Investigators create “brain map” of key epigenetic processes (August 14, 2012)
Also of Note
- Request for Information: Increasing Enrollment in Alzheimers Disease and Related Clinical Trials and Studies
-
Preventing Alzheimer’s Disease: What Do We Know?
New booklet looks at current research on risk factors and prevention strategies - Read about NIA’s minority research and training activities in NIA’s LINKS e-newsletter
-
New online tip sheets for Alzheimer’s caregivers:
- Bathing (PDF, 619K)
- Disaster Preparedness (PDF, 613K)
- End-of-Life Care (PDF, 156K)
- Going Out (PDF, 401K)
- Grooming and Dressing (PDF, 168K)
- Incontinence (PDF, 501K)
- Managing Medicines (PDF, 625K)
- Managing Personality and Behavior Changes (PDF, 748K)
- Money Problems (PDF, 156K)
Clinical Trials Now Recruiting
Major Studies:
- Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2)
- Dominantly Inherited Alzheimer’s Network (DIAN)
- Systolic Blood Pressure Intervention Trial, Memory and Cognition in Decreased Hypertension (SPRINT-MIND)
Drug Trials:
- Gantenerumab for Prodromal Alzheimer's Disease
- Intravenous Immunoglobulin (IGIV), 10%, in Alzheimer's Disease
- RG1662 in Individuals with Down Syndrome
- RO4602522 in Patients with Moderate Alzheimer Disease on Donepezil or Rivastigmine Therapy
Other Trials:
- ADvance Deep Brain Stimulation in Patients with Mild Probable Alzheimer's Disease
- Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) IV
- Metabolic Cerebral Imaging in Incipient Dementia
Exercise Trials:
- Cognitive Benefits of Aerobic Exercise Across the Age Span
- Dose Response Study of Aerobic Exercise in Older Adults
- Fit & Active Seniors Trial (FAST)
Connections Newsletter -- Summer 2012
Features
- Researchers, Advocates Gather to Accelerate Alzheimer's Research
- Exendin-4: From Lizard to Laboratory...and Beyond
Research Highlights
- Experimental Alzheimer’s drug shows promise in small, early-phase clinical studies (July 12, 2012)
- Cancer drug bexarotene reverses Alzheimer’s deficits in mice (June 1, 2012)
- Protein involved in brain-wave maintenance linked to Alzheimer’s-related cognitive dysfunction (June 1, 2012)
- NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk (May 16, 2012)
- Obama administration presents national plan to fight Alzheimer’s disease (May 15, 2012)
- Genes involved in age-related declines in brain volume may play role in Alzheimer’s disease (April 16, 2012)
- New study identifies role of large protein fragment in blocking amyloid build-up (April 13, 2012)
- Smoking in middle age is associated with increased rate of cognitive decline in men (March 22, 2012)
- Brain imaging shows lifetime cognitive activity may influence Alzheimer’s disease risk (February 1, 2012)
-
Pilot clinical trial shows nicotine patch may improve cognition in older people with memory loss
(January 10, 2012)
Clinical Trials Now Recruiting
- New, improved Alzheimer's clinical trials finder launched
- Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2)
- Dominantly Inherited Alzheimer Network (DIAN)
- Exendin-4 for the Treatment of Alzheimer’s Disease
- Resveratrol for Alzheimer’s Disease
- Systolic Blood Pressure Intervention Trial—Memory and Cognition in Decreased Hypertension (SPRINT-MIND)
Also of Note
- Register now for "Unveiling the NIH Toolbox" meeting, Sept. 10-11
- New online tip sheets for Alzheimer’s caregivers
- NIH steps up efforts on clinical research awareness
- Organ donation–You’re never too old to make a difference
- NIH partners with new public TV project
- Sign up for NIA and ADEAR email alerts
Page last updated: August 1, 2013
